← Back to Search

MAP-I for Chronic Insomnia (CARES Trial)

N/A
Waitlist Available
Led By Michael R Irwin, M.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

CARES Trial Summary

This trial is testing a treatment for insomnia in caregivers of Alzheimer's patients, which may help improve their sleep and reduce their risk for developing chronic diseases.

Eligible Conditions
  • Chronic Insomnia

CARES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Cellular aging
Daytime dysfunction
Inflammation
+1 more

CARES Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MAP-IExperimental Treatment1 Intervention
The Mindful Awareness Practices (MAPs) is a validated and curriculum-based meditation similar to Mindfulness Based Stress Reduction, with the exception that MAPs does not include a day-long retreat or yoga and hence takes a more practical and accessible approach that focuses specifically on the practice of mindfulness and its application in everyday life. (http://marc.ucla.edu) MAP for Insomnia (MAP-I) is a modified version of MAPs that incorporates practice prior to bed, use of practice in the bed during night-time awakenings, and daily body scan.
Group II: CBT-IActive Control1 Intervention
Cognitive behavioral therapy for insomnia (CBT-I), considered the treatment of choice by the American Academy of Sleep Medicine, combines cognitive therapy, stimulus control, sleep restriction, sleep hygiene, and relaxation to improve sleep outcomes, with demonstrated efficacy in adult and older adult populations
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MAP-I
2018
N/A
~140

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,526 Previous Clinical Trials
10,275,765 Total Patients Enrolled
Michael R Irwin, M.D.Principal InvestigatorUniversity of California, Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers
Michael Irwin, MD 2018. "Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03538574.
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top